| 13 October- Morning 9 AM CEST |
14 October- Morning 9 AM CEST |
|
Session 2. Antibody-based Therapeutics |
Session 1. Antibody Discovery and Engineering |
| 13 October - Afternoon 2 PM CEST |
14 October - Afternoon 2 PM CEST |
|
Session 4. Humoral Immunity & |
Session 5. Computational Antibody Engineering |
Date: 13 October 2025 (Monday)
Time: 9:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
|
CEST |
Speaker |
Title |
|
9:00–9:20 |
Prof. Dr. Arne Skerra |
Welcome and Opening Remarks |
|
9:20–9:30 |
Dr. Patrick Chames |
Welcome from the Session Chair |
|
9:30–10:00 |
Prof. Dr. Stefan Dübel |
Remotely controlled Antibodies |
|
10:00–10:25 |
Dr. Thomas Böldicke |
Recombinant Antibodies and Recombinant T-cells against Intracellular Neoantigens |
|
10:25–10:40 |
Ainhoa Goenaga Aramendi |
Antibody-Functionalized Nanoparticles: A Targeted Drug Delivery Strategy |
|
10:40–10:55 |
Salman Shahid |
Cryo-EM Structures of HCV E2 Bound to Neutralizing and Non-Neutralizing Antibodies Using Engineered Domain-Swapped Bivalent Fabs as Fiducial Markers |
|
10:55–11:00 |
Inesa Stonkutė |
Predictive Biomarkers for Monoclonal Antibody Therapy Response in Oral Squamous Cell Carcinoma: A Systematic Review |
|
11:00–11:05 |
Archana Damavarapu |
Role of Antibodies in HAV Vaccines and Therapeutic Approaches: Insights into Immunological Strategies |
|
11:05–11:10 |
Empuluri Haritha |
Antibodies Involved in Allergic Conditions: Mechanisms and Therapeutic Insights |
|
11:10–11:15 |
Palla Nikitha Selected Poster Presenter |
Antibody-Drug Conjugates: Redefining Chemotherapy with Targeted Precision |
|
11:15–11:20 |
Peruri Likitha Selected Poster Presenter |
Targeted Drug Delivery in Lung Cancer Using Antibodies: A Precision Approach to Therapy |
|
11:20–11:25 |
Chinthu Krishnaveni Selected Poster Presenter |
Architects of Immunity: Structural Insights into Antibodies for Novel Biomedical Applications |
|
11:25–11:30 |
Aluru Uma Priyanka Selected Poster Presenter |
Advancements in Antibody Technology: From Bispecifics to AI-Driven Therapeutics |
|
11:30–14:00 |
Break |
Date: 13 October 2025 (Monday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
|
CEST |
Speaker |
Title |
|
14:00–14:10 |
Dr. Cecile King |
Welcome from Session Chair |
|
14:10–14:40 |
Professor Guglielmo Lucchese Invited Speaker |
Autoantibodies in post-COVD-syndrome |
|
14:40–14:45 |
Madalen Arribas Galarreta Selected Poster Presenter |
A broad-spectrum SARS-CoV-2 immunization strategy targeting the highly conserved MPER of the Spike protein |
|
14:45–14:55 |
Professor Sophia Karagiannis |
Welcome from Session Chair |
|
14:55–15:25 |
Prof. Dr. Nick Devoogdt Keynote Speaker |
Imaging tumor immunity with nanobody tracers: from camel to bedside |
|
15:25–15:55 |
Prof. Dr. Christian Klein |
The present and future of bispecific antibodies for cancer therapy |
|
15:55–16:20 |
Volker Morath |
PET Tracking of Cell and Gene Therapies Using a Novel Lanthanide•DTPA-Binding Anticalin Reporter Gene |
|
16:20–16:25 |
Krishnaveni Manubolu |
Targeting the Tumor Microenvironment with Radiolabeled Antibodies: Bridging Immunotherapy and Molecular Imaging |
Date: 14 October 2025 (Tuesday)
Time: 9:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
|
CEST |
Speaker |
Title |
|
9:00–9:10 |
Prof. Dr. Serge Muyldermans |
Welcome from the Session Chair |
|
9:10–9:35 |
Professor Jan Steyaert |
Engineering Nanobodies for structural Biology, molecular pharmacology and drug discovery |
|
9:35–10:05 |
Professor Shohei Koide |
Creating and targeting cancer-specific neoantigens by design |
|
10:05–10:35 |
Prof. Dr. Harald Kolmar |
Discovery and optimization of bispecific antibodies with prescribed binding characteristics and biophysical properties |
|
10:35–11:00 |
Alessa Schaffrath |
Selection of nanobodies from LamaMice |
|
11:00–11:05 |
Mattias Collin |
Chemoenzymatically glycan engineered monoclonal IgG antibodies against Streptococcus pyogenes |
|
11:05–14:00 |
Break |
Date: 14 October 2025 (Tuesday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
|
CEST |
Speaker |
Title |
|
14:00–14:10 |
Prof. Dr. Arne Skerra |
Welcome from Event Chair |
|
14:10–14:40 |
Prof. Dr. Sai Reddy |
Generative design of antibody Fc variants with synthetic and programmable immune function |
|
14:40–15:10 |
Dr. Pietro Sormanni Keynote Speaker |
Antibody discovery and engineering by computational design |
|
15:10–15:40 |
Prof. Dr. Christoph Schmidt |
Undue complement activation: Therapeutic strategies and hidden pitfalls |
|
15:40–15:45 |
Prof. Dr. Arne Skerra Event Chair |
Closing Remarks |